top of page
Addressing a worldwide epidemic:
How to boost liver functions in patients?
Chronic liver disease affects 100 Million people world wide with no current treatment other than liver transplantation
​
​No solution exists other than organ transplantation, which only treats a fraction of patients
Cirrhosis is debilitating and affects relatively younger patients in their most productive years​​
​
New technologies and solutions are needed to boost liver function in terminally ill patients​
Khufu therapeutics is a pre-seed stage biotechnology company which employs bioengineering technologies to address liver disease.
Innovation - Driven Solutions
Khufu Therapeutics focuses on liver bioengineering platforms that permanently restore liver mass, architecture, and function, in patients with liver disease.
A vicious cycle of increasing cirrhosis, increasing mortality, and lack of treatments is escalating liver disease worldwide
Khufu's founder has over 20 years of research and experience in medicine and surgery, bioengineering, tissue engineering, stem cells, regenerative engineering, synthetic biology, and bionformatics
bottom of page